Clinical trial
Citalopram in Irritable Bowel Syndrome
NCT00477165 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00477165 |
|---|---|
| Title | Citalopram in Irritable Bowel Syndrome |
| Official title | Effect of Citalopram on Clinical Symptoms and Visceral Sensitivity in Patients With Irritable Bowel Syndrome |
| Lead sponsor | Stanford University, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Irritable Bowel Syndrome |
| Intervention type | Drug |
| Interventions | Citalopram, Placebo |
| Enrollment | 54 |
| Start date | Apr 1, 2001 |
| Primary completion | Jun 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | May 22, 2007 |
| Last update posted | Apr 17, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: